PhRMA Announces Research & Hope Award Winners

Article

The organization announced the winners of the 2016 awards at a dinner on Sept. 13 in Washington DC.

On Sept. 13, 2016, Pharmaceutical Research and Manufacturers of America (PhRMA) announced the recipients of the 2016 Research & Hope Awards. This year, PhRMA recognized patient advocates and researchers for their efforts to advance the treatment and care of patients with autoimmune diseases. The organization was joined by 22 patient and community health organizations at a dinner in Washington DC to honor the award winners.

For more information on the awards recipients, visit PhRMA’s website. Recipients of the PhRMA 2016 Research & Hope Awards are:

The PhRMA Research & Hope Award for Biopharmaceutical Industry ResearchJohn Medich, PhD, vice-president, immunology clinical development, AbbVie

The PhRMA Research & Hope Award for Community ChampionMila Ferrer, community and social media manager, Hispanic market, Diabetes Hands Foundation

The PhRMA Research & Hope Award for Excellence in Advocacy & ActivismVirginia T. Ladd, president and executive director, American Autoimmune Related Diseases Association, Inc.

The PhRMA Research & Hope Award for Government ResearchLisa G. Rider, MD, deputy chief, environmental autoimmunity group, National Institute of Environmental Health Sciences, National Institutes of Health

The PhRMA Research & Hope Award for Nonprofit ResearchJoan T. Merrill, MD, chief advisor, clinical development, Lupus Foundation of America

The PhRMA Research & Hope Award for Visibility & ProgressParker Lentini, patient and advocate.

Source: PhRMA

Recent Videos
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Adam Sherlock, CEO of Qinecsa Solutions
Related Content
© 2025 MJH Life Sciences

All rights reserved.